Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

127 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Audit system on Quality of breast cancer diagnosis and Treatment (QT): results from the survey on screen-detected lesions in Italy, 2003-2004.
Ponti A, Mano MP, Distante V, Taffurelli M, Naldoni C, Zangirolami F, Vettorazzi M, Zorzi M, Pagano G, Federici A, Baiocchi D, Bordon R, Tomatis M, Mantellini P, Cataliotti L, Rosselli del Turco M, Segnan N. Ponti A, et al. Among authors: naldoni c. Epidemiol Prev. 2006 Jan-Feb;30(1 Suppl 3):59-63. Epidemiol Prev. 2006. PMID: 16937847 Free article.
HPV triage for low grade (L-SIL) cytology is appropriate for women over 35 in mass cervical cancer screening using liquid based cytology.
Ronco G, Cuzick J, Segnan N, Brezzi S, Carozzi F, Folicaldi S, Dalla Palma P, Del Mistro A, Gillio-Tos A, Giubilato P, Naldoni C, Polla E, Iossa A, Zorzi M, Confortini M, Giorgi-Rossi P; NTCC working group. Ronco G, et al. Among authors: naldoni c. Eur J Cancer. 2007 Feb;43(3):476-80. doi: 10.1016/j.ejca.2006.11.013. Epub 2007 Jan 12. Eur J Cancer. 2007. PMID: 17223540
The New Technologies for Cervical Cancer Screening randomised controlled trial. An overview of results during the first phase of recruitment.
Ronco G, Brezzi S, Carozzi F, Dalla Palma P, Giorgi-Rossi P, Minucci D, Naldoni C, Segnan N, Zappa M, Zorzi M, Cuzick J; NTCC study group. Ronco G, et al. Among authors: naldoni c. Gynecol Oncol. 2007 Oct;107(1 Suppl 1):S230-2. doi: 10.1016/j.ygyno.2007.07.021. Epub 2007 Sep 6. Gynecol Oncol. 2007. PMID: 17822751 Clinical Trial.
Audit system on quality of breast cancer diagnosis and treatment (QT): results from the survey on screen-detected lesions in Italy, 2004.
Ponti A, Mano MP, Distante V, Baiocchi D, Bordon R, Federici A, Frigerio A, Mantellini P, Naldoni C, Pagano G, Sapino A, Taffurelli M, Tomatis M, Vettorazzi M, Zangirolami F, Zorzi M, Cataliotti L, Rosselli Del Turco M, Segnan N. Ponti A, et al. Among authors: naldoni c. Epidemiol Prev. 2007 Mar-Jun;31(2-3 Suppl 2):69-75. Epidemiol Prev. 2007. PMID: 17824364 Free article.
Results at recruitment from a randomized controlled trial comparing human papillomavirus testing alone with conventional cytology as the primary cervical cancer screening test.
Ronco G, Giorgi-Rossi P, Carozzi F, Confortini M, Dalla Palma P, Del Mistro A, Gillio-Tos A, Minucci D, Naldoni C, Rizzolo R, Schincaglia P, Volante R, Zappa M, Zorzi M, Cuzick J, Segnan N; New Technologies for Cervical Cancer Screening Working Group. Ronco G, et al. Among authors: naldoni c. J Natl Cancer Inst. 2008 Apr 2;100(7):492-501. doi: 10.1093/jnci/djn065. Epub 2008 Mar 25. J Natl Cancer Inst. 2008. PMID: 18364502 Clinical Trial.
127 results